Routine quarterly SEBI compliance certificate filed
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.0 pts more than Nifty Microcap 250 and 1.1 pts more than its Medical Equipment & Supplies peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Choksi Asia filed its quarterly compliance certificate under SEBI's Regulation 74(5) for July to September 2026. The certificate from its registrar Adroit Corporate Services confirms that all dematerialisation requests received during the quarter were properly processed and securities were confirmed to depositories within the required 15-day timeline. This is a routine regulatory filing with no material business impact.
No material impact on shareholders; routine regulatory compliance filing only.